These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

433 related items for PubMed ID: 15038942

  • 1. Topical antibacterial therapy for mycobacterial keratitis: potential for surgical prophylaxis and treatment.
    Abshire R, Cockrum P, Crider J, Schlech B.
    Clin Ther; 2004 Feb; 26(2):191-6. PubMed ID: 15038942
    [Abstract] [Full Text] [Related]

  • 2. Topical ciprofloxacin for treating nontuberculous mycobacterial keratitis.
    Hu FR, Luh KT.
    Ophthalmology; 1998 Feb; 105(2):269-72. PubMed ID: 9479286
    [Abstract] [Full Text] [Related]

  • 3. In vitro antibiotic susceptibility of rapidly growing nontuberculous mycobacteria isolated from patients with microbial keratitis.
    Reddy AK, Garg P, Babu KH, Gopinathan U, Sharma S.
    Curr Eye Res; 2010 Mar; 35(3):225-9. PubMed ID: 20373881
    [Abstract] [Full Text] [Related]

  • 4. In vitro activity of fluoroquinolones against Mycobacterium abscessus and Mycobacterium chelonae causing infectious keratitis after LASIK in Brazil.
    Höfling-Lima AL, de Freitas D, Sampaio JL, Leão SC, Contarini P.
    Cornea; 2005 Aug; 24(6):730-4. PubMed ID: 16015094
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vitro activities of DC-159a, a novel fluoroquinolone, against Mycobacterium species.
    Disratthakit A, Doi N.
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2684-6. PubMed ID: 20368403
    [Abstract] [Full Text] [Related]

  • 11. High prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan.
    Yang SC, Hsueh PR, Lai HC, Teng LJ, Huang LM, Chen JM, Wang SK, Shie DC, Ho SW, Luh KT.
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1958-62. PubMed ID: 12760874
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Successful treatment of Keratitis caused by Mycobacterium chelonae and an overview of previous cases in Europe.
    Kukla R, Nouzovska K, Ryskova L, Rozsivalova P, Pavlik I, Bostik P.
    Ann Clin Microbiol Antimicrob; 2024 Oct 09; 23(1):92. PubMed ID: 39385246
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Review of third-and fourth-generation fluoroquinolones in ophthalmology: in-vitro and in-vivo efficacy.
    Scoper SV.
    Adv Ther; 2008 Oct 09; 25(10):979-94. PubMed ID: 18836691
    [Abstract] [Full Text] [Related]

  • 17. Nontuberculous mycobacterial ocular infections--comparing the clinical and microbiological characteristics between Mycobacterium abscessus and Mycobacterium massiliense.
    Chu HS, Chang SC, Shen EP, Hu FR.
    PLoS One; 2015 Oct 09; 10(1):e0116236. PubMed ID: 25581038
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.